EE265 Health, Productivity and Budget Impact of Vaccinating 50-64 Year Old Employees in Austria Against Herpes Zoster With Recombinant Zoster Vaccine
Dec 1, 2022, 00:00 AM
10.1016/j.jval.2022.09.513
https://www.valueinhealthjournal.com/article/S1098-3015(22)02717-6/fulltext
Section Title :
Section Order :
10039
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)02717-6&doi=10.1016/j.jval.2022.09.513